OXALIPLATIN
Generic: OXALIPLATIN
Eugia US LLCManufacturer
INTRAVENOUSRoute
OXALIPLATINActive Substance
2017-09-06Original Approval
OXALIPLATIN is FDA application ANDA205529, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DIARRHOEA
7,073 reports
2
NAUSEA
5,658 reports
3
OFF LABEL USE
4,825 reports
4
VOMITING
4,521 reports
5
NEUROPATHY PERIPHERAL
4,511 reports
6
DISEASE PROGRESSION
4,383 reports
7
NEUTROPENIA
4,328 reports
8
THROMBOCYTOPENIA
3,640 reports
9
DYSPNOEA
3,140 reports
10
FATIGUE
2,954 reports